Webinar

Challenges with Fast Enrolling Post-Operative Acute Pain Studies

There are a lot of resources on how to deal with slow enrolling studies, but what about challenges with studies that enroll very quickly?  Enrollment can be very fast for post-operative acute pain studies which brings with it unique challenges in study execution.

This webinar addresses:

  • Differences between bunionectomy and abdominoplasty models
  • The importance of rater and site training
  • Considerations for data collection and analysis



Becky Baggett

Becky Baggett

Senior Project Director

A pain expert at Rho, Ms. Baggett has over 14 years of clinical trial experience. In the last 8 years alone, she has led 3 chronic pain studies and 7 acute pain studies across 5 programs. This success is partly due to her keen understanding of the unique challenges inherent to chronic and acute pain studies such as accurate pain reporting for efficacy endpoints, operational challenges resulting from swift enrollment on elective surgical models for acute pain, and subject retention challenges for single-injection chronic pain studies. In 2017, Ms. Baggett earned her Regulatory Affairs Certification (RAC) which provides her with…
Ben Vaughn

Ben Vaughn

Chief Strategist, Biostatistics & Protocol Design

A proven leader in the industry for more than 20 years, Mr. Ben Vaughn serves as Rho’s Chief Strategist for Biostatistics and Protocol Design. In this role, he utilizes his extensive expertise to guide sponsors through marketing applications, regulatory interactions, and the design and analysis of analgesia trials. Mr. Vaughn has supported over 50 pain trials, over 30 marketing applications, and 5 FDA advisory committee meetings (both back room and bullpen) over the course of his career. In the past year alone, he has had speaking roles in 12 FDA Type A, B, and C meetings. His experience spans many…
Marina Acosta Enslen

Marina Acosta Enslen

Director, Clinical Management

Marina Acosta Enslen has been involved in the conduct of clinical trials for 20 years, working in academia, pharmaceutical, and CRO markets. She has experience working on NIH and industry funded Phase 1 – 4 global clinical trials. Much of her career has been focused in infectious disease, primarily HIV/AIDS and HPV research providing clinical trial coordination, monitoring and clinical team leadership. Ms. Acosta Enslen’s broad experience from multiple perspectives and strong understanding of clinical trial management particular to infectious disease trials has allowed her to successfully lead teams. Prior to joining Rho, Ms. Acosta Enslen’s experience included the conduct…